Overview
After almost a year of rigorous research, the COVID-19 vaccine is finally on the horizon. By early 2021, an approved vaccine could be out for public use. But the real challenge that lies ahead of pharmaceutical companies, government and healthcare departments, and countries at large is ensuring fast, effective and equitable distribution of the vaccine to put an end to this global misery. In this strategic research article, Locus suggests an optimal design for the required supply chain (cold chain) network for vaccine transportation and distribution in the United States.
A two-layer distribution model has been proposed in this paper to determine the optimal location for the warehouses. Locus’ K-Means clustering algorithm has been deployed on the US population data to cluster U.S. zip codes to various regional warehouses. Five mother warehouse locations and 26 regional warehouse locations have been determined along with a one-on-one mapping of every zip code in the United States with the regional warehouses by using the output of the algorithm.
Key Takeaways from the White Paper
In this research article, you get a complete understanding of the ongoing vaccine development initiatives worldwide, the various vaccine distribution plans around the world and the challenges underlying in the process of vaccine distribution, and the gaps in the global cold supply chain. Read on to get real-world data-driven insights on a strategic, well-planned, and seamless vaccine distribution network in the USA.
